Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03272126
Other study ID # TromsøEndo-2017-1
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date December 1, 2017
Est. completion date May 1, 2018

Study information

Verified date September 2017
Source University of Tromso
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Vitamin D is a hormone with effects not only on the skeleton, but on most tissues in the body. Lack of vitamin D is associated with cardio-vascular disease (CVD), type 2 diabetes, cancer, infectious and immunological diseases, as well as risk factors for these diseases. However, intervention studies with vitamin D have been inconclusive regarding diseases and risk factors. This could be due to inclusion of subjects already vitamin D sufficient, and short and underpowered studies. In addition, there are indications that the dosing regimens may be important, so that daily doses with vitamin D are more efficient than intermittent doses, which so far have been generally used. This could be related to the concentration of circulating and thereby intracellular vitamin D concentrations, which probably is dependent on daily vitamin D doses. This will be tested in the present study where 60 subjects will be randomized to vitamin D 160 000 once, vitamin D 4000 IU/day, or placebo for four weeks. The primary endpoints will be effects on serum hepcidin and plasma cathelicidin after 4 weeks, with effects on serum PTH, RNA expression and microRNA in peripheral blood, telomerase activity in peripheral blood mononuclear cells and the ration between serum 1,25(OH)2D and 24,25(OH)2D as secondary endpoints.


Recruitment information / eligibility

Status Completed
Enrollment 61
Est. completion date May 1, 2018
Est. primary completion date April 1, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 70 Years
Eligibility Inclusion Criteria:- Males and females 20 - 70 years

- 20 kg/m2 > BMI < 35 kg/m2

- systolic BP < 175 mmHg, diastolic BP < 105 mmHg

- Serum 25(OH)D level < 50 nmol/L. Serum 25(OH)D < 50 nmol/L is considered as vitamin D deficiency, and accordingly, effects of vitamin D supplementation will be easier to detect than if the included subjects were vitamin D sufficient.

- Hgb, SR, CRP, creatinine < 130 umol/L in males, < 120 umol/L in females, calcium, FT4 and TSH within the normal reference range; ASAT < 90 mU/L ALAT < 140 U/L, HbA1c < 6.6 %

- The subjects must agree not to take any vitamin D supplementation, including cod liver oil or "mølje", use solarium or go on sunny vacation during the intervention period.

Exclusion Criteria:

- subjects allergic to peanuts

- subjects with primary hyperparathyroidism

- granulomatous diseases (sarcoidosis, tuberculosis, Wegner's granulomatosis)

- diabetes

- renal stones the last five years

- subjects seriously ill (or with chronic disease) and unfit for participation in the study (as judged by one of the study doctors)

- subjects using vitamin D supplements exceeding 800 IU per day or active vitamin D drugs (Rocaltrol or Etalpha)

- pregnancy

Study Design


Intervention

Drug:
Vitamin D
vitamin D given as bolus versus daily dosing
Placebo
identical looking as vitamin D

Locations

Country Name City State
Norway University Hospital of North Norway Tromsø

Sponsors (1)

Lead Sponsor Collaborator
University of Tromso

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hepcidin change Difference between vitamin D given as a bolus 160 000IU vs 4000 IU regarding change in serum hepcidin 4 weeks
Secondary Difference in serum PTH after 1 month Difference between vitamin D given as a bolus 160 000IU vs 4000 IU regarding change in serum PTH, cathelicidin, RNA expression and micro RNA in peripheral blood, telomerase activity and the ratio between 1,25(OH)2D and 24,25(OH)2D, after 1 month 4 weeks
Secondary Difference in micro RNA Expression after 1 month Difference between vitamin D given as a bolus 160 000IU vs 4000 IU 4 weeks
Secondary Difference in serum cathelicidin after 1 month Difference between vitamin D given as a bolus 160 000IU vs 4000 IU 4 weeks
Secondary Difference in RNA Expression after 1 month Difference between vitamin D given as a bolus 160 000IU vs 4000 IU 4 weeks
Secondary Difference in telomerase Activity after 1 month Difference between vitamin D given as a bolus 160 000IU vs 4000 IU 4 weeks
Secondary Difference in ratio between 1,24(OH)2D and 24,24(OH)2D after 1 month Difference between vitamin D given as a bolus 160 000IU vs 4000 IU 4 weeks
See also
  Status Clinical Trial Phase
Completed NCT05376865 - Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers N/A
Not yet recruiting NCT05214040 - Vitamin D Insufficiency inVestigation Among hospitaLizeD Inpatients
Completed NCT02802449 - To Study the Nutri-Genomic Response of Vit-D Supplementation in African-Americans N/A
Recruiting NCT00992797 - Diabetes Intervention Trial With Vitamin D in Subjects of Nordic and Sub-Indian Ethnicity Phase 2
Completed NCT00960232 - Vitamin D, Blood Pressure, Lipids, Infection and Depression Phase 3
Completed NCT02543671 - Investigation of Vitamin D3 Enriched, Reduced-fat Yellow Cheese Efficacy to Prevent Vitamin D Deficiency N/A
Completed NCT01793402 - Vitamin D Status and the Adequacy of Vitamin D Intake in Early Preterm Infants N/A
Completed NCT01240213 - Vitamin D, Diet and Activity Study N/A
Completed NCT00887666 - Pilot Study: Hypovitaminosis D, Hyperparathyroidism and Hypomagnesemia in Patients With Congestive Heart Failure N/A
Completed NCT05425914 - Impact of Vitamin D3 Supplementation in Non-Sjogren Dry Eye Patients With Low Serum Vitamin D Level Phase 3
Not yet recruiting NCT04829487 - The Role of Vitamin D Supplementation on Pain in Women With Primary Dysmenorrhea and Hypovitaminosis D N/A
Completed NCT05372224 - Effect of Vitamin D and Denosumab on Bone Remodelling in Women With Postmenopausal Osteoporosis N/A
Completed NCT02101151 - Effect of Vitamin D Supplementation on the Metabolic Control and Body Composition of Type 2 Diabetes Subjects in Ajman (UAE) N/A
Completed NCT00695474 - Vitamin D and Type 2 Diabetes - a Cross Sectional Study N/A
Completed NCT02534714 - Analysis of Hypovitaminosis D and Osteopenia/Osteoporosis in Spinal Disease Patients Who Underwent a Spinal Fusion at Illinois Neurological Institute, Peoria, IL., a Retrospective Review From November 1, 2012 to October 31, 2014 and Prospective Pilot From July 1, 2015-June 30, 2016
Completed NCT02434380 - Effect of Vitamin D Replacement on Maternal and Neonatal Outcomes Phase 3
Withdrawn NCT00944606 - Vitamin D Versus Placebo in the Treatment of Vague Musculoskeletal Pain in Children N/A
Recruiting NCT06138249 - Cholecalciferol and Calcifediol Are Both Useful to Improve Vitamin D Serum Levels N/A
Completed NCT05346419 - Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal Patients N/A
Completed NCT03381378 - Vitamin D and Hand Grip Strength at 5 Years in Odense Child Cohort N/A